237 related articles for article (PubMed ID: 23692415)
1. Cost-effectiveness of prospective red blood cell antigen matching to prevent alloimmunization among sickle cell patients.
Kacker S; Ness PM; Savage WJ; Frick KD; Shirey RS; King KE; Tobian AA
Transfusion; 2014 Jan; 54(1):86-97. PubMed ID: 23692415
[TBL] [Abstract][Full Text] [Related]
2. Economic evaluation of a hypothetical screening assay for alloimmunization risk among transfused patients with sickle cell disease.
Kacker S; Ness PM; Savage WJ; Frick KD; Shirey RS; King KE; Tobian AA
Transfusion; 2014 Aug; 54(8):2034-44. PubMed ID: 24571485
[TBL] [Abstract][Full Text] [Related]
3. Impact of Red Blood Cell Antigen Matching on Alloimmunization and Transfusion Complications in Patients with Sickle Cell Disease: A Systematic Review.
Fasano RM; Meyer EK; Branscomb J; White MS; Gibson RW; Eckman JR
Transfus Med Rev; 2019 Jan; 33(1):12-23. PubMed ID: 30122266
[TBL] [Abstract][Full Text] [Related]
4. Medical and economic implications of strategies to prevent alloimmunization in sickle cell disease.
Gehrie EA; Ness PM; Bloch EM; Kacker S; Tobian AAR
Transfusion; 2017 Sep; 57(9):2267-2276. PubMed ID: 28653325
[TBL] [Abstract][Full Text] [Related]
5. Antigen matching for transfusion support in Brazilian female patients with sickle cell disease to reduce RBC alloimmunization.
Muniz JG; Arnoni C; Medeiros R; Vendrame T; Cortez A; S Afonso J; Latini F; Castilho L; Girão M
Transfusion; 2021 Aug; 61(8):2458-2467. PubMed ID: 34121200
[TBL] [Abstract][Full Text] [Related]
6. The future of red blood cell alloimmunization risk reduction.
Kacker S; Ness PM; Shirey RS; Savage WJ; King KE; Tobian AA
Transfusion; 2015 Jan; 55(1):222-4. PubMed ID: 25582240
[No Abstract] [Full Text] [Related]
7. The future of red blood cell alloimmunization risk reduction.
Karafin MS; Denomme GA; Bryant BJ
Transfusion; 2015 Jan; 55(1):220-1. PubMed ID: 25582238
[No Abstract] [Full Text] [Related]
8. Prospective antigen matching strategies fail to fit the model.
Webb J; Chou ST
Transfusion; 2015 Jan; 55(1):221-2. PubMed ID: 25582239
[No Abstract] [Full Text] [Related]
9. Red blood cell alloimmunization in sickle cell disease: prevalence in 2010.
Miller ST; Kim HY; Weiner DL; Wager CG; Gallagher D; Styles LA; Dampier CD; Roseff SD;
Transfusion; 2013 Apr; 53(4):704-9. PubMed ID: 22804353
[TBL] [Abstract][Full Text] [Related]
10. Extended red blood cell antigen matching for transfusions in sickle cell disease: a review of a 14-year experience from a single center (CME).
Lasalle-Williams M; Nuss R; Le T; Cole L; Hassell K; Murphy JR; Ambruso DR
Transfusion; 2011 Aug; 51(8):1732-9. PubMed ID: 21332724
[TBL] [Abstract][Full Text] [Related]
11. Red blood cell minor antigen mismatches during chronic transfusion therapy for sickle cell anemia.
Yee MEM; Josephson CD; Winkler AM; Webb J; Luban NLC; Leong T; Stowell SR; Fasano RM
Transfusion; 2017 Nov; 57(11):2738-2746. PubMed ID: 28840600
[TBL] [Abstract][Full Text] [Related]
12. Red blood cell alloimmunization in sickle cell disease: assessment of transfusion protocols during two time periods.
Campbell-Lee SA; Gvozdjan K; Choi KM; Chen YF; Saraf SL; Hsu LL; Gordeuk VR; Strauss RG; Triulzi DJ
Transfusion; 2018 Jul; 58(7):1588-1596. PubMed ID: 29570817
[TBL] [Abstract][Full Text] [Related]
13. High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors.
Chou ST; Jackson T; Vege S; Smith-Whitley K; Friedman DF; Westhoff CM
Blood; 2013 Aug; 122(6):1062-71. PubMed ID: 23723452
[TBL] [Abstract][Full Text] [Related]
14. Alloimmunization in sickle cell anemia in the era of extended red cell typing.
O'Suoji C; Liem RI; Mack AK; Kingsberry P; Ramsey G; Thompson AA
Pediatr Blood Cancer; 2013 Sep; 60(9):1487-91. PubMed ID: 23508932
[TBL] [Abstract][Full Text] [Related]
15. Predicting the effect of transfusing only phenotype-matched RBCs to patients with sickle cell disease: theoretical and practical implications.
Castro O; Sandler SG; Houston-Yu P; Rana S
Transfusion; 2002 Jun; 42(6):684-90. PubMed ID: 12147019
[TBL] [Abstract][Full Text] [Related]
16. Red Blood Cell Alloimmunization in Transfused Patients With Sickle Cell Disease in Sub-Saharan Africa; a Systematic Review and Meta-Analysis.
Boateng LA; Ngoma AM; Bates I; Schonewille H
Transfus Med Rev; 2019 Jul; 33(3):162-169. PubMed ID: 31345590
[TBL] [Abstract][Full Text] [Related]
17. Effects of prophylactic red blood cell (RBC) transfusion with extended antigen matching on alloimmunization in patients with Sickle Cell Disease (SCD).
Leal I; Dos Santos TD; Gilli S; Castilho L
Transfus Apher Sci; 2023 Dec; 62(6):103813. PubMed ID: 37743224
[TBL] [Abstract][Full Text] [Related]
18. RH genotypes and red cell alloimmunization rates in chronically transfused patients with sickle cell disease: A multisite study in the USA.
Israelyan N; Vege S; Friedman DF; Zhang Z; Uter S; Fasano RM; Yee M; Piccone C; Kelly S; Hankins JS; Zheng Y; Westhoff CM; Chou ST
Transfusion; 2024 Mar; 64(3):526-535. PubMed ID: 38289184
[TBL] [Abstract][Full Text] [Related]
19. Red cell exchange does not appear to increase the rate of allo- and auto-immunization in chronically transfused children with sickle cell disease.
Venkateswaran L; Teruya J; Bustillos C; Mahoney D; Mueller BU
Pediatr Blood Cancer; 2011 Aug; 57(2):294-6. PubMed ID: 21298771
[TBL] [Abstract][Full Text] [Related]
20. Relevance of blood groups in transfusion of sickle cell disease patients.
Noizat-Pirenne F
C R Biol; 2013 Mar; 336(3):152-8. PubMed ID: 23643398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
